| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 2,154 | 4,266 | 5,534 | 4,964 | | Cost of Revenue | 62 | 4,169 |
-
| (2,319) | | | Gross Profit | 2,092 | 97 | 5,534 | 7,283 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,315 | 973 | 3,676 | 6,302 | | Non Recurring | (5,819) | 11,967 | 3,848 | 588 | | Others | 212 | 18,102 | 279 | 3,886 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,384 | (30,945) | (2,269) | (3,493) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 92 | 271 |
-
| 8,237 | | Earnings Before Interest And Taxes | 5,384 | (30,985) | (2,229) | 4,736 | | Interest Expense | 923 | 1,366 | 1,436 | 1,353 | | Income Before Tax | 4,461 | (32,351) | (3,665) | 3,383 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 217 | (42) | (44) | (44) | | | | Net Income From Continuing Ops | 4,874 | (34,253) | (3,665) | 3,383 | | | Non-recurring Events | | Discontinued Operations | (10,137) | (8,083) | 42 | (1,177) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,263) | (42,336) | (3,623) | 2,206 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,263) | ($42,336) | ($3,623) | $2,206 |
|
0.22% Nasdaq 
Income Statement
